CASSANDRA JACKSON: Open Payments
NPI 1053998781 · SIOUX FALLS, SD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$450 in 20 payments from 15 companies in 2025. Trend: 2023 $165 · 2024 $202 · 2025 $450
Food & beverage: $450
| Company | Payments | Amount |
|---|---|---|
| Janssen Scientific Affairs, LLC | 1 | $129 |
| E.R. Squibb & Sons, L.L.C. | 2 | $47 |
| Janssen Pharmaceuticals, Inc | 3 | $41 |
| Neurocrine BioSciences, Inc. | 2 | $32 |
| Otsuka America Pharmaceutical, Inc. | 2 | $32 |
| Vanda Pharmaceuticals Inc. | 1 | $28 |
| ABBVIE INC. | 1 | $19 |
| Tris Pharma Inc | 1 | $18 |
| HARMONY BIOSCIENCES LLC | 1 | $17 |
| ACADIA Pharmaceuticals Inc | 1 | $16 |
Products named: INVEGA SUSTENNA, COBENFY, INGREZZA, FANAPT, VRAYLAR, ABILIFY MAINTENA, Dyanavel XR, WAKIX.
Industry payments across SD — which companies pay providers there.
